Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | PTGIR | P43119 | 1/20 | 0.56 |
| ▸ | ACHE | P22303 | 2/20 | 0.53 |
| ▸ | BACE1 | P56817 | 1/20 | 0.53 |
| ▸ | CHKA | P35790 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1586714 | 1.00 | SIGMAR1 (0.63) | SIGMAR1SMN1; SMN2MEN1KMT2APTGIR | |
| Hydrochloric Acid SCHEMBL11534460 | 0.98 | SIGMAR1 (0.61) | SIGMAR1SMN1; SMN2MEN1KMT2APTGIR | |
| SCHEMBL11452801 | 0.90 | SIGMAR1 (0.55) | SIGMAR1SMN1; SMN2MEN1KMT2APTGIR | |
| SCHEMBL28603694 | 0.90 | SIGMAR1 (0.55) | SIGMAR1SMN1; SMN2MEN1KMT2APTGIR | |
| Hydrochloric Acid SCHEMBL4222373 | 0.89 | SIGMAR1 (0.54) | SIGMAR1SMN1; SMN2MEN1KMT2APTGIR | |
| Trifluoroacetic Acid SCHEMBL1921476 | 0.87 | SIGMAR1 (0.55) | SIGMAR1MEN1KMT2AACHE | |
| SCHEMBL8320248 | 0.85 | HRH3 (0.69) | SIGMAR1SMN1; SMN2MEN1KMT2APTGIR | |
| SCHEMBL17967832 | 0.84 | KDM4E (0.58) | SMN1; SMN2MEN1KMT2A | |
| SCHEMBL10499190 | 0.84 | SIGMAR1 (0.73) | SIGMAR1 | |
| SCHEMBL19285228 | 0.84 | SIGMAR1 (0.85) | SIGMAR1SMN1; SMN2PTGIRCHKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1056744-A1 | 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES | Aventis Pharmaceuticals Inc. (US) | 2000-12-06 | — | — | EP | disclosed |
| WO-1999043675-A1 | 6,9-DISUBSTITUTED 2-[TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES | AVENTIS PHARMACEUTICALS INC. (US) | 1999-09-02 | — | — | WO | disclosed |